Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Secretogranin 3 ELISA Kit (AC2869)
Cat.#: ASET-1458
Specifications
Description Human Secretogranin 3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Secretogranin 3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.019 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1844 Human PSD95 ELISA Kit (AC3255) Quantitative inquiry ASET-1840 Human Neurexin 1 ELISA Kit (AC3251) Quantitative inquiry ASET-2416 Human SRD5A1 ELISA Kit (AC3827) Quantitative inquiry ASET-1741 Human eNOS ELISA Kit (AC3152) Quantitative inquiry ASET-1600 Human LAMP1 ELISA Kit (AC3011) Quantitative inquiry ASET-1613 Mouse NEGR1 ELISA Kit (AC3024) Quantitative inquiry ASET-2412 Human Pet1 ELISA Kit (AC3823) Quantitative inquiry ASET-1056 Human EN2 ELISA Kit (AC2467) Quantitative inquiry ASET-1542 Human SLUG ELISA Kit (AC2953) Quantitative inquiry ASET-1533 Human Ephrin A1 ELISA Kit (AC2944) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket